Innovators are Greg Batcheller, Thomas Hedner, Werner Schubert, Jörgen Johnsson, Olov Sterner, Christer Sjögren and Malgorzata Sznitowska.


Greg Batcheller

B.Sc. (Econ), J.D, LL.M. Chairman of Xintela AB, Monocl AB, Saga Diagnostics AB and ImmuneBiotech Medical AB. Partner of Business Research Life Sciences Ltd. Advisor to pharmaceutical, biotech, medical device and other high technology companies. Former Project Leader of DuoCort AB and AcuCort AB. Innovator in Laccure AB and Trophea AB.


Thomas Hedner

MD, PhD (Medicine and Economics), Professor in Clinical Pharmacology at the Department of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden. Leading researcher in Cardiovascular Medicine. Head of the biomedical entrepreneurship program at the University of Gothenburg. Author of more than 400 scientific publications. Innovator in multiple Aqilion project companies.

Jörgen Johnsson 

Former CEO of Pharmacia Consumer Healthcare worldwide, Senior Vice President of Pharmacia Corporation and member of Pharmacia’s Executive Management Group from 1995-2000. Founder of P.U.L.S. AB (now known as AQILION AB), Vice Chairman of Aqilion and board member of Laccure AB. Innovator in multiple Aqilion project companies.



Christer Sjögren

DVM, PhD, former consulting professor in Experimental Obstetrics and Gynecology at Uppsala University, Associate Professor in Pharmacology at the Veterinary Faculty of SLU (Swedish University of Agricultural Sciences). Former research director at Pharmacia, Perstorp, Novo Nordisk, Head of Clinical Operations at Quintiles, Vice President at CDC, Director at the Centre for Research on Pharmaceuticals at Lund University, Sweden, and board member of Vinnova's (Sweden's innovation agency) national program for pharmaceuticals, biotechnology and medical technology.




Werner Schubert

MD and has since 1983 been a specialist in obstetrics and gynecology. PhD 1995 from University of Gothenburg, Sweden.
Dr Schubert is running a private practice in gynecology in Gothenburg.



Olov Sterner

M.Sc, PhD, Professor in Organic Chemistry, Faculty of Science, Lund University, Sweden. Major research fields are biologically active secondary metabolites and medicinal chemistry. Author or co-author of more than 420 publications in scientific journals, 30 patents/patent applications, and 5 text books in organic chemistry/chemical toxicology. Board member of Glactone Pharma AB. Innovator in multiple Aqilion project companies.


Malgorzata Sznitowska 

Professor and Head of Pharmaceutical Technology at the Medical University of Gdansk, Poland. She is the author of several books and scientifi c papers in the area of galenics and has access to galenic development laboratories with all basic galenic technologies. She is a member of the advisory committee to the Polish medicinal products regulatory authority. She has worked on product development for the pharma industry related to infusions, topical preparations (ointments, vagitoria, etc) as well as oral formulations (tablets, solutions etc).









Recently Updated

Laccure ends collaboration…

PRESS RELEASE Helsingborg, Sweden, February 12, 2019 Combe...

Laccure AB and…

PRESS RELEASE Laccure AB, a Swedish development company,...

Recipharm and Laccure…

Leading contract development and manufacturing organisation (CDMO)...

Recipharm och Laccure…

Recipharm, ett ledande CDMO-företag (Contract Development and...



Translate this site with Google

English French German Italian Russian Spanish Swedish